(Q33420599)

English

Observational study of corrected count increments after transfusion of platelets treated with riboflavin pathogen reduction technology in additive solutions

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Observational study of corrected count increments after transfusion of platelets treated with riboflavin pathogen reduction technology in additive solutions (English)

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

based on heuristic

inferred from title

Hendrik B. Feys

object named as

Hendrik B Feys

5

0 references

author name string

Sarah M Drawz

1

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Susanne Marschner

2

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Martha Yañez

3

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Alfonso García de Coca

4

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Dries Deeren

6

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

José Coene

7

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

23 February 2015

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

55

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

7

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

1745-1751

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

Blood still kills: six strategies to further reduce allogeneic blood transfusion-related mortality

1 reference

https://api.crossref.org/works/10.1111%2FTRF.13026

21 January 2018

Emerging Pathogens - How Safe is Blood?

1 reference

https://api.crossref.org/works/10.1111%2FTRF.13026

21 January 2018

Pathogen Reduction Technology Treatment of Platelets, Plasma and Whole Blood Using Riboflavin and UV Light.

1 reference

https://api.crossref.org/works/10.1111%2FTRF.13026

21 January 2018

Risk-reduction strategies for platelet transfusion in the United States.

1 reference

https://api.crossref.org/works/10.1111%2FTRF.13026

21 January 2018

Evaluation of the Mirasol pathogen [corrected] reduction technology system against Babesia microti in apheresis platelets and plasma

1 reference

https://api.crossref.org/works/10.1111%2FTRF.13026

21 January 2018

A laboratory comparison of pathogen reduction technology treatment and culture of platelet products for addressing bacterial contamination concerns.

1 reference

https://api.crossref.org/works/10.1111%2FTRF.13026

21 January 2018

Photochemical inactivation of chikungunya virus in plasma and platelets using the Mirasol pathogen reduction technology system

1 reference

https://api.crossref.org/works/10.1111%2FTRF.13026

21 January 2018

Pathogen inactivation technology applied to a blood component collected from an asymptomatic carrier of Leishmania infantum: a case report.

1 reference

https://api.crossref.org/works/10.1111%2FTRF.13026

21 January 2018

A randomized controlled clinical trial evaluating the performance and safety of platelets treated with MIRASOL pathogen reduction technology

1 reference

https://api.crossref.org/works/10.1111%2FTRF.13026

21 January 2018

The impact of platelet additive solution apheresis platelets on allergic transfusion reactions and corrected count increment (CME).

1 reference

https://api.crossref.org/works/10.1111%2FTRF.13026

21 January 2018

Exploratory studies of extended storage of apheresis platelets in a platelet additive solution (PAS).

1 reference

https://api.crossref.org/works/10.1111%2FTRF.13026

21 January 2018

A comparison of adverse reaction rates for PAS C versus plasma platelet units

1 reference

https://api.crossref.org/works/10.1111%2FTRF.13026

21 January 2018

Hemostatic function of buffy coat platelets in additive solution treated with pathogen reduction technology.

1 reference

https://api.crossref.org/works/10.1111%2FTRF.13026

21 January 2018

Pathogen reduction treatment using riboflavin and ultraviolet light impairs platelet reactivity toward specific agonists in vitro.

1 reference

https://api.crossref.org/works/10.1111%2FTRF.13026

21 January 2018

Effects of riboflavin and ultraviolet light treatment on platelet thrombus formation on collagen via integrin αIIbβ3 activation.

1 reference

https://api.crossref.org/works/10.1111%2FTRF.13026

21 January 2018

A multicenter inspection of the swirling phenomenon in platelet concentrates prepared in routine practice. Biomedical Excellence for Safer Transfusion (BEST) Working Party of the International Society of Blood Transfusion.

1 reference

https://api.crossref.org/works/10.1111%2FTRF.13026

21 January 2018

Guidelines for the use of platelet transfusions

1 reference

https://api.crossref.org/works/10.1111%2FTRF.13026

21 January 2018

Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial

1 reference

https://api.crossref.org/works/10.1111%2FTRF.13026

21 January 2018

A prospective observational cohort safety study of 5106 platelet transfusions with components prepared with photochemical pathogen inactivation treatment

1 reference

https://api.crossref.org/works/10.1111%2FTRF.13026

21 January 2018

Use of additive solutions and pathogen inactivation treatment of platelet components in a regional blood center: impact on patient outcomes and component utilization during a 3-year period

1 reference

https://api.crossref.org/works/10.1111%2FTRF.13026

21 January 2018

Universal adoption of pathogen inactivation of platelet components: impact on platelet and red blood cell component use.

1 reference

https://api.crossref.org/works/10.1111%2FTRF.13026

21 January 2018

The incidence and impact of thrombocytopenia in myelodysplastic syndromes

1 reference

https://api.crossref.org/works/10.1111%2FTRF.13026

21 January 2018

Identifiers

10.1111/TRF.13026

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

26 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33420599&oldid=1603029503"